Oisun Jung, PhD

Oisun Jung, PhD

Postdoc, Rapraeger Lab, UW-Madison

oisun@wisc.edu

Advisor: Dr. Alan Rapraeger

Graduation: 3/2018
Research Interests: The syndecan family of matrix receptors and synstatin therapeutic peptide in Multiple Myeloma

Oisun Jung, PhD

Biography

Publications

Beauvais DM, Jung O, Yang Y, Sanderson RD, Rapraeger AC. Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth. Cancer Res. 2016 Sep 1;76(17):4981-93. doi: 10.1158/0008-5472.CAN-16-0232. Epub 2016 Jun 30. PubMed PMID: 27364558; PubMed Central PMCID: PMC5010496. Jung O, Trapp-Stamborski V, Purushothaman A, Jin H, Wang H, Sanderson RD, Rapraeger AC. Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins. Oncogenesis. 2016 Feb 29;5:e202. doi: 10.1038/oncsis.2016.5. PubMed PMID: 26926788; PubMed Central PMCID: PMC5154350.